Heart rate variability: for real doctors. Translation from the Russian version of the book, published at Kharkiv, 2010, 131 p.
The basics and practice of the clinical use of the technology of heart rate variability are outlined for doctors of all specialties and students of medical faculties of universities.
9. Regulation in the disease
The optimizing effect of drugs on regulation
Regulation is an active participant in the disease.
The nature of regulation prescribes the maintenance of the disease along the best possible path with the highest possible recovery.
Therefore, in the disease, in most cases, the regulation changes in this way.
The doctor simply follows her, controlling it changes and its compliance with the conditions of recovery.
The control method is HRV technology.
Interventions in regulation are required when it shies away from the adequate natural development of the disease.
Our experience with “cardiovascular” patients shows that, in most cases, drugs have an optimizing effect on HRV indices, lowering them in patients with initially high and increasing with initially low levels.
Moreover, this action of medications does not depend on which class they are off – ACE inhibitors, angiotensin receptor inhibitors, beta-adrenergic receptor blockers.
A unique position of beta-adrenergic receptor blockers among the listed drugs is that only with their use, it is possible to improve regulation in cases of its persistent and in-depth decrease.